Hyperpigmentation is where skincare marketing gets least honest, because dark spots are stubborn, the gold-standard drug has baggage and patience does not sell serums. Azelaic acid is the quiet exception: a prescription-strength active with head-to-head trial data against hydroquinone, a side-effect profile mild enough for pregnancy and a particular advantage in darker skin. Here is what it can and cannot do for melasma and post-inflammatory hyperpigmentation, with the evidence attached.

Melasma and PIH are different problems with overlapping treatment

Melasma is a chronic pigmentary condition driven by hormones, genetics and above all light exposure. It shows up as symmetric brown patches on the cheeks, forehead and upper lip, most often in women, often beginning in pregnancy or with hormonal contraception. It is managed, not cured. Whatever fades it, sun exposure brings back.

Post-inflammatory hyperpigmentation (PIH) is the mark left after inflammation: the brown or gray-brown stain where a pimple, a burn, eczema or an overaggressive procedure used to be. It is more common and more persistent in deeper skin tones. Unlike melasma, PIH genuinely resolves once the pigment clears, provided the inflammation that caused it has stopped.

The distinction matters for expectations. PIH treatment has a finish line. Melasma treatment is maintenance.

How azelaic acid works on pigment

Azelaic acid is a naturally occurring dicarboxylic acid. For pigment, its relevant action is inhibition of tyrosinase, the rate-limiting enzyme in melanin synthesis. Two properties make it unusually well suited to hyperpigmentation in real patients.

First, it appears selective for hyperactive and abnormal melanocytes, the overproducing cells in melasma and PIH, with little effect on normally pigmented skin. In practice this means it fades the dark patch without bleaching a halo of normal skin around it, a real failure mode with stronger agents. Second, it is also anti-inflammatory and comedolytic, which is why it carries acne and rosacea approvals. For the extremely common patient whose PIH comes from acne that is still active, one product treats the cause and the stain at the same time.

The evidence, specifically

The reference comparison is hydroquinone, the long-standing gold standard for epidermal pigment. Balina and Graupe randomized over 300 women with melasma to azelaic acid 20% cream or hydroquinone 4% cream for 24 weeks. Azelaic acid performed comparably to hydroquinone on lightening, with no statistically significant difference in overall outcomes and without hydroquinone's specific risks. An earlier double-blind trial against hydroquinone 2% found azelaic acid superior. For darker-skinned patients with facial hyperpigmentation, a 1998 randomized vehicle-controlled trial of azelaic acid 20% in patients with Fitzpatrick types IV to VI showed significant improvement over vehicle with good tolerability.

Why does this matter when hydroquinone exists and works? Because hydroquinone has constraints azelaic acid does not. It is generally limited to cycles of a few months because long-term continuous use carries a risk of exogenous ochronosis, a paradoxical blue-black pigmentation that is very difficult to reverse and is more frequently reported in darker skin. It is avoided in pregnancy. And since 2020 it is no longer available over the counter in the US. Azelaic acid has no ochronosis signal, no cycle limit and is considered one of the safest topical actives in pregnancy, which is directly relevant given that pregnancy is one of the most common triggers of melasma.

The honest hierarchy: for severe melasma, short courses of hydroquinone or triple-combination cream under clinical supervision still fade pigment fastest. Azelaic acid is the strongest option among the agents you can use continuously, in pregnancy and in deep skin tones without the specific risks above.

Using it properly

Prescription strengths are the 15% gel or foam and the 20% cream; the 20% cream is the strength used in the melasma trials. Apply a thin layer twice daily to clean dry skin over the whole affected area. Expect tingling, mild stinging or itching in the first weeks; it almost always settles. Visible lightening typically begins around eight weeks, with the trials running 24 weeks for full effect. Judge the result in months, not weeks, and take a baseline photo in consistent lighting, because gradual fading is easy to miss.

Azelaic acid layers well. Common evidence-supported pairings include a topical retinoid at night to accelerate pigment turnover, vitamin C in the morning and niacinamide. Introduce one thing at a time if your skin is reactive.

The part that decides whether any of this works

Pigment treatment without rigorous photoprotection is rowing against the current. For melasma specifically, visible light, not just UV, stimulates pigmentation in darker skin types, which means an ordinary chemical sunscreen is not enough. The standard advice from pigmentary disorder specialists: a tinted mineral sunscreen containing iron oxides, every morning, reapplied with sun exposure, all year. This single habit predicts treatment success better than the choice between any two topical agents.

Two more failure modes worth naming. For PIH, the stain will keep regenerating as long as the inflammation does, so active acne has to be treated, and picking has to stop. For melasma, hormonal contributors are worth a conversation with your clinician, since estrogen-containing contraception can maintain it.

The bottom line

Azelaic acid is the rare pigment treatment where the trial data, the safety profile and the marketing claims roughly agree. It matched hydroquinone 4% in a six-month randomized melasma trial, it is safe for continuous use, in pregnancy and in skin of color, and it doubles as treatment for the acne and rosacea that cause much of the PIH it treats. It is slow, and it cannot outwork unprotected sun exposure. A licensed clinician can confirm whether your pigmentation pattern fits melasma, PIH or something that needs in-person evaluation, and build a regimen around prescription-strength azelaic acid if it fits.

Start your skin intake and get a pigment plan with evidence behind it.

This article is for general education and is not medical advice. A licensed clinician should review your history before starting or changing any prescription treatment.

Sources

  • Balina LM, Graupe K. The treatment of melasma: 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30(12):893-895. https://pubmed.ncbi.nlm.nih.gov/1816137/
  • Verallo-Rowell VM, Verallo V, Graupe K, Lopez-Villafuerte L, Garcia-Lopez M. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh). 1989;143:58-61. https://pubmed.ncbi.nlm.nih.gov/2528260/
  • Lowe NJ, Rizk D, Grimes P, Billips M, Pincus S. Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients. Clin Ther. 1998;20(5):945-959. https://pubmed.ncbi.nlm.nih.gov/9829445/
  • Lyons AB, Trullas C, Kohli I, Hamzavi IH, Lim HW. Photoprotection beyond ultraviolet radiation: a review of tinted sunscreens. J Am Acad Dermatol. 2021;84(5):1393-1397. https://pubmed.ncbi.nlm.nih.gov/32335182/